Risk of stroke in patients unresponsive til antiplatelet therapy

Phase 1

• Conditions: Apoplexia cerebri; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2011-004748-23-DK
• Lead Sponsor: eurologisk Afdeling

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10-28
• Last Update Posted: 5 December 2016

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

patientens with first-time ischemic apoplexia cerebri who recieves clopidogrel
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 150
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 150

Exclusion Criteria

haemorrhagic stroke
Known cancer
other antiplatelet therapy treatment

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified